Purchase Order 1232SA25P0065
- Not listed
- This federal contract award is for a chemistry analyzer from Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The $9,280.72 firm fixed-price purchase order was awarded on October 1, 2021 by the Defense Health Agency, with an ultimate completion date of September 30, 2026. The contract does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostic products, laboratory instruments, and associated...
- This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at $108,800.00, is for preventative maintenance services to be performed by March 31, 2028. Roche Diagnostics has previously received awards from various federal agencies, including the Department of...
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $1,176,942.17, is a delivery order awarded by the Department of Veterans Affairs (VA) under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration (GSA) Schedule contract. The award is for CHEMISTRY ANALYZERS CPRR, with an ultimate...
- The Department of the Air Force awarded a firm fixed-price delivery order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the procurement of a chemistry analyzer. The contract is not set aside and has a potential value of $1,708,242.30. The contract is associated with Roche's existing General Services Administration (GSA) Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). Roche Diagnostics is a foreign-owned, for-profit organization that...
- This is a $311,081.10 firm-fixed-price purchase order contract awarded by the Veterans Integrated Service Network 9 of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostic products and laboratory instruments. The contract is for the provision of an ANALYZER and has an ultimate completion date of April 19, 2027. The award is not associated with a set-aside program. Roche Diagnostics holds multiple Indefinite...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer and distributor of in vitro diagnostics, to provide maintenance services for a Roche HE 600 analyzer. The $172,500.57 contract was awarded on February 27, 2019, with a completion date of February 21, 2023. Roche Diagnostics has previously received awards from the VA, Department of Defense, Department of Health...
- This is a federal contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $295,346.07 Firm Fixed Price Definitive Contract provides clinical chemistry analyzers, reagents, test kits, and associated laboratory products and services to VA hospitals without a set-aside designation....
- This is a firm fixed-price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for preventative maintenance services on Roche's ROCEH diagnostic clinical analyzers. The $197,652.60 contract has an ultimate completion date of March 31, 2023 and is not set aside. Roche Diagnostics is a global in vitro diagnostics manufacturer that has received numerous federal contract awards across...
- This federal contract award was made by the Defense Health Agency to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $887,473.92 firm fixed-price delivery order was placed against Roche's General Services Administration (GSA) Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). It does not have a set-aside...
- This is a firm fixed-price delivery order contract awarded by the Department of the Air Force Air Combat Command to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for chemistry analyzer maintenance services. The contract was awarded on December 27, 2017, with a potential value of $111,675.41 and a completion date of December 27, 2018. The contract is not set aside and was issued under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration...
Roche Diagnostics Corporation was awarded a firm fixed-price purchase order valued at $45,368 for a maintenance and service agreement supporting a Roche C303 chemistry analyzer. The contract, awarded September 1, 2025, extends through August 31, 2029, and will be performed at a location in Davis, California. This is a non-set-aside award from a civilian federal agency within the Pacific West Area. The chemistry analyzer is a critical laboratory instrument used for clinical testing and diagnostic support across federal healthcare systems. Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory instruments, is a well-established federal contractor with an extensive portfolio of agreements across the Department of Veterans Affairs, Defense Health Agency, and other federal healthcare agencies. The company maintains multiple Indefinite Delivery Contracts and Blanket Purchase Agreements under General Services Administration Schedule contracts, including the Critical Analyzers, Laboratory schedule. This maintenance agreement represents a continuation of Roche's support for federal laboratory operations, ensuring the C303 analyzer remains operational and available for patient care and medical research activities throughout the contract period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 8/28/25 |